Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology

Luwen Zhang1,2, Wei Wang3, Xincan Liu2

  • 1The First Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, Henan, China.

PubMed

Insights

Traditional Chinese Medicine (TCM) offers promising treatments for cardiovascular diseases (CVDs) by targeting inflammation, oxidative stress, and fibrosis. This review explores how TCM compounds regulate key pathways for effective CVD management.

Area of Science:

  • Biomedical Science
  • Pharmacology
  • Cardiology

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of mortality, with increasing incidence.
  • Pathophysiological mechanisms of CVDs involve inflammation, oxidative stress, autophagy, and myocardial fibrosis.
  • Traditional Chinese Medicine (TCM) presents potential therapeutic strategies for CVDs.

Purpose of the Study:

  • To review the latest advancements in understanding TCM's role in treating CVDs.
  • To explore how TCM compounds modulate key signaling pathways implicated in CVDs.

Main Methods:

  • Literature review of recent studies on TCM and cardiovascular disease.
  • Analysis of TCM's effects on inflammation, oxidative stress, autophagy, and fibrosis.
  • Examination of TCM compounds' influence on relevant signaling pathways.

Main Results:

  • TCM demonstrates synergistic effects by targeting multiple components and pathways.
  • TCM can modulate inflammatory responses and mitigate oxidative stress in CVD models.
  • TCM aids in regulating autophagy and promoting myocardial fibrosis repair.

Conclusions:

  • TCM compounds offer a multi-targeted approach for managing CVDs.
  • Further research into TCM mechanisms can lead to novel therapeutic strategies for cardiovascular health.
  • TCM shows significant potential in addressing the complex pathophysiology of CVDs.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
315
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
488
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
414
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.3K